Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Folling's disease].

S O Lie1

  • 1Barneklinikken, Rikshospitalet, Oslo. s.o.lie@klinmed.uio.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|December 8, 2000
PubMed
Summary
This summary is machine-generated.

Asbjørn Følling discovered phenylketonuria (PKU) in 1934, revealing the first link between metabolic disease and brain development. His pioneering work in Norway advanced medical science and understanding of developmental disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of metallic objects on digital radiographs with convolutional neural networks: A MRI screening tool.

Radiography (London, England : 1995)·2022
Same author

Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials.

Leukemia·2005
Same author

Unexpected medical coincidences require systematic and careful strategies: an example.

Archives of disease in childhood·2003
Same author

[Children with cancer--great progress, a lot of good news and some disappointments].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2001
Same author

CD99 signals caspase-independent T cell death.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Multisystem Langerhans-cell histiocytosis with life-threatening pulmonary involvement--good response to cyclosporine A.

Medical and pediatric oncology·2000
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Area of Science:

  • Medical Science
  • Biochemistry
  • Neuroscience

Background:

  • Asbjørn Følling, a Norwegian medical scientist, was born in 1888.
  • He identified phenylketonuria (PKU) in 1934, a significant breakthrough in metabolic disease research.

Discussion:

  • This article details Følling's life, his groundbreaking discovery of PKU, and his subsequent scientific contributions.
  • The discovery established the first known connection between a metabolic disorder and impaired brain development.

Key Insights:

  • Phenylketonuria (PKU) is a metabolic disease affecting brain development.
  • Følling's work highlighted the critical role of metabolism in neurological health.

Outlook:

  • Følling's discovery paved the way for future research into inborn errors of metabolism and their impact on neurodevelopment.

Related Experiment Videos

  • His legacy underscores the importance of scientific inquiry in uncovering complex biological mechanisms.